RxDoctor Payments Data

Elliott Nipper, MD

Orthopaedic Trauma · Monroe, LANPI 1902811300

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $7,953 of the $9,515 with a category attached, or 83.6%. Stryker accounts for 82.0% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $2,712 and has fallen 54.3% since, to $1,239 in 2025.

$9,515in general payments, 2019–2025

Across 173 payments — averaging $55.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$8K
  • Zimmer Biomet$1K
  • Curonix LLC$181
  • Midsouth Orthopedics Inc.$176
  • Johnson & Johnson$169
  • Endo Pharmaceuticals Inc.$69
  • plus $88 from 4 others

What the payments were for

  • Travel & lodging$1,39815%
  • Food & beverage$7,95384%
  • Education$1642%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker142$7,801
Zimmer Biomet12$1,031
Curonix LLC1$181
Midsouth Orthopedics Inc.2$176
Johnson & Johnson5$169
Endo Pharmaceuticals Inc.5$69
AbbVie2$38
Pfizer2$24
Amgen1$17
Medela LLC1$9

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few orthopaedic trauma providers in Louisianato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$388,875
Medicare patients
682
Services billed
5,978

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban121$42,262
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen312$1,806
Celecoxib52$593
Gabapentin71$586
Mupirocin111$563
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen52$393
Tramadol Hcl73$179
Doxycycline Hyclate17$171
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim30$119
Diclofenac Sodium12$118
Meloxicam21$103
Methocarbamol12$65

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$24$42,262121 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few orthopaedic trauma providers in Louisianaon file to place this against a meaningful peer group, so we don't.

Other orthopaedic trauma in Monroe

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →